Browse the corpus

Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.

3 passages

referencesuptodate· REFERENCES· item f25_57_26518

REFERENCES Bowden R, Chandrasekar P, White MH, et al, “A Double-Blind, Randomized, Controlled Trial of Amphotericin B Colloidal Dispersion versus Amphotericin B for Treatment of Invasive Aspergillosis in Immunocompromised Patients,” Clin Infect Dis , 2002, 35(4):359-66. [PubMed 12145716 ] Centers for Disease Control and Prevention, “Guidelines for the Prevention and Treatment of Opportunistic Infections Among HIV-Exposed and HIV-Infected Children: Recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics,” MMWR Recomm Rep , 2009, 58(RR-11):1-166. Available at file://aidsinfo.nih.gov/contentfiles/Pediatric_OI.pdf [PubMed 19730409 ] Chapman SW, Dismukes WE, Proia LA, et al, "Clinical Practice Guidelines for the Management of Blastomycosis: 2008 Update by the Infectious Diseases Society of America," Clin Infect Dis , 2008, 46(12):1801-12. [PubMed 18462107 ] Edwards JE Jr, Bodey GP, Bowden RA, et al, “International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections,” Clin Infect Dis , 1997, 25(1):43-59. [PubMed 9243032 ] Eggimann P, Francioli P, Bille J, et al, “Fluconazole Prophylaxis Prevents Intra-abdominal Candidiasis in High-Risk Surgical Patients,” Crit Care Med , 1999, 27(6):1066-72. [PubMed 10397206 ] Fichtenbaum CJ, Zackin R, Rajicic N, et al, “Amphotericin B Oral Suspension for Fluconazole-Refractory Oral Candidiasis in Persons With HIV Infection. Adult AIDS Clinical Trials Group Study Team 295,” AIDS , 2000, 14(7):845-52. [PubMed 10839593 ] Galgiani JN, Ampel NM, Blair JE, et al, "Coccidioidomycosis," Clin Infect Dis , 2005, 41(9):1217-23. [PubMed 16206093 ] Hiemenz JW and Walsh TJ, “Lipid Formulations of Amphotericin B: Recent Progress and Future Directions,” Clin Infect Dis , 1996, 22(Suppl 2):133-44. [PubMed 8824978 ] Kauffman CA, Bustamante B, Chapman SW, et al, "Clinical Practice Guidelines for the Management of Sporotrichosis: 2007 Update by the Infectious Diseases Society of America," Clin Infect Dis , 2007, 45(10):1255-65. [PubMed 17968818 ] King CT, Rogers PD, Cleary JD, et al, "Antifungal Therapy During Pregnancy," Clin Infect Dis , 1998, 27(5):1151-60. [PubMed 9827262 ]

referencesuptodate· REFERENCES· item f25_57_26518

Kauffman CA, Bustamante B, Chapman SW, et al, "Clinical Practice Guidelines for the Management of Sporotrichosis: 2007 Update by the Infectious Diseases Society of America," Clin Infect Dis , 2007, 45(10):1255-65. [PubMed 17968818 ] King CT, Rogers PD, Cleary JD, et al, "Antifungal Therapy During Pregnancy," Clin Infect Dis , 1998, 27(5):1151-60. [PubMed 9827262 ] Lister J, “Amphotericin B Lipid Complex (Abelcet®) in the Treatment of Invasive Mycoses: The North American Experience,” Eur J Haematol Suppl , 1996, 57:18-23. [PubMed 8706812 ] Lyman CA and Walsh TJ, “Systemically Administered Antifungal Agents. A Review of Their Clinical Pharmacology and Therapeutic Applications,” Drugs , 1992, 44(1):9-35. [PubMed 1379913 ] Mactal-Haaf C, Hoffman M, and Kuchta A, "Use of Anti-infective Agents During Lactation, Part 3: Antivirals, Antifungals, and Urinary Antiseptics," J Hum Lact , 2001, 17(2):160-6. [PubMed 11847833 ] Mora-Duarte J, Betts R, Rotstein C, et al, “Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis,” N Engl J Med , 2002, 347(25):2020-9. [PubMed 12490683 ] Pappas PG, Kauffman CA, Andes D, et al, "Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America," Clin Infect Dis , 2009, 48(5):503-35. [PubMed 19191635 ] Patel R, “Antifungal Agents. Part I. Amphotericin B Preparations and Flucytosine,” Mayo Clin Proc , 1998, 73(12):1205-25. [PubMed 9868423 ] Paterson DL, David K, Mrsic M, et al, “Pre-medication Practices and Incidence of Infusion-related Reactions in Patients Receiving AMPHOTEC®: Data from the Patients Registry of Amphotericin B Cholesteryl Sulfate Complex for Injection Clinical Tolerability (PRoACT) Registry,” J Antimicrob Chemother , 2008, 62(6):1392-1400. [PubMed 18812423 ] Perfect JR, Dismukes WE, Dromer F, et al, "Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America," Clin Infect Dis , 2010, 50(3):291-322. [PubMed 20047480 ] Prentice HG, Hann IM, Herbrecht R, et al, “A Randomized Comparison of Liposomal Versus Conventional Amphotericin B for the Treatment of Pyrexia of Unknown Origin in Neutropenic Patients,” Br J Haematol , 1997, 98(3):711-8. [PubMed 9332329 ]

referencesuptodate· REFERENCES· item f25_57_26518

Perfect JR, Dismukes WE, Dromer F, et al, "Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America," Clin Infect Dis , 2010, 50(3):291-322. [PubMed 20047480 ] Prentice HG, Hann IM, Herbrecht R, et al, “A Randomized Comparison of Liposomal Versus Conventional Amphotericin B for the Treatment of Pyrexia of Unknown Origin in Neutropenic Patients,” Br J Haematol , 1997, 98(3):711-8. [PubMed 9332329 ] Rex JH, Bennett JE, and Sugar AM, “A Randomized Trial Comparing Fluconazole With Amphotericin B for the Treatment of Candidemia in Patients Without Neutropenia. Candidemia Study Group and the National Institute,” N Engl J Med , 1994, 331(20):1325-30. [PubMed 7935701 ] Rex JH, Pappas PG, Karchmer AW, et al, “A Randomized and Blinded Multicenter Trial of High-Dose Fluconazole Plus Placebo Versus Fluconazole Plus Amphotericin B as Therapy for Candidemia and Its Consequences in Nonneutropenic Subjects,” Clin Infect Dis , 2003, 36(10):1221-8. [PubMed 12746765 ] Slain D, “Lipid-Based Amphotericin B for the Treatment of Fungal Infections,” Pharmacotherapy , 1999, 19(3):306-23. [PubMed 10221369 ] Wheat LJ, Freifeld AG, Kleiman MB, et al, "Clinical Practice Guidelines for the Management of Patients With Histoplasmosis: 2007 Update by the Infectious Diseases Society of America," Clin Infect Dis , 2007, 45(7):807-25. [PubMed 17806045 ] Topic 8710 Version 37.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [0504-118.195.65.248-3548BCC041-S244013.14]